A low preoperative HALP score is a notable biomarker for poorer survival in patients diagnosed with primary liver cancer undergoing hepatectomy. Being easily detectable and cost-effective, the HALP score is a valuable addition to existing cancer prognosis assessment tools in clinical practice.
Zhang et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: